**Charity Registration Number: 1196208**
## **THE MRS SARDAR SAIED CHARITABLE TRUST ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025**
1
## **CONTENTS**
1. Legal and administrative information
2. Trustees report
3. Grant-making policy
4. Future plans
2
## **LEGAL AND ADMINISTRATIVE INFORMATION**
Trustees
Dr Faisal Awan Dr Afshan Butt Mr M B N Butt
Secretary Dr Afshan Butt
Charity number 1196208
Registered address 18 Riverside Close Kingston upon Thames KT12JF London
3
## **TRUSTEE REPORT**
For the year ended 31 March 2025
The trustees present their annual report and financial statements for the year ended 31 March 2025
## **Structure, governance and management**
The Mrs Sardar Saied Charitable Trust commenced its operations on 19/10/2021 following the adoption of its constitution and was registered as a Charitable Incorporated Organisation (CIO) with the Charity Commission, charity registration number 1196208
## **Trustees in 2025:**
Our charity is governed by a board of trustees that oversees grant distribution, financial management, and compliance with charity regulations. The Trustees do not receive any remuneration for their work as Trustees.
Dr Faisal Awan (Chairperson)
Mr M B N Butt (Treasurer)
Dr Afshan Butt (Secretary)
Our operations comply with the Charity Commission's guidelines and continue to seek ways to improve governance and transparency.
## **Objectives and Activities**
Our charity was established to honour the legacy of our late aunt, who had a lifelong commitment to financially supporting disadvantaged students, with a focus on medicine and engineering.
She bequeathed an endowment donation in her estate. She wished for this capital to be invested, with the returns allocated to providing grants for disadvantaged undergraduate students.
Given the small endowment, we wanted to preserve the principal as an investment to generate charitable funds. This year, we invested in a medium-risk fund that aligns with our investment policy following due diligence.
During the year, we agreed to support two medical students at the Pears Cumbria School of Medicine (PCSM), a joint initiative between Imperial College London and the University of Cumbria, which welcomed its first cohort of 58 graduate-entry students in autumn 2025. The School has been established to address severe health inequality and social deprivation in
4
Cumbria and the wider North West by training future doctors with a strong commitment to serving the local community.
Our funding contributed to two £5,000 bursaries awarded to students from wideningparticipation backgrounds within this inaugural cohort. These bursaries were provided to help students overcome the significant financial barriers they face in the first year of the course, when the tuition fee loan covers only 63% of the course fees and students are not yet eligible for NHS bursaries or tuition grants. Without this support, many students from low-income or underrepresented backgrounds would not be able to take up or continue their medical studies.
The School received approximately 700 applications for its first 58 places, with around 60% of students coming from households that would not traditionally consider medicine, including care leavers and families with no previous experience of higher education. A large proportion of students were also recruited locally from an area with historically low tertiary education participation. Bursaries are awarded on the basis of financial need and widening-participation criteria, with applicants required to submit a statement explaining how the support will enable them to succeed and contribute to the School.
By funding two bursaries, we directly advanced our charitable objects of promoting education and relieving financial hardship. This support also contributes to long-term public benefit by helping build a locally trained medical workforce better placed to improve healthcare provision and outcomes in one of the most deprived regions of the UK.
The commitment was made in this financial year, however, the payments were made in June 2025 and hence will be reflected in next year’s financial accounting.
5
## **GRANT MAKING POLICY**
We have revised our policy and intend to focus on donating to established educational institutions with strong systems for vetting applicants and for directly providing grants. This decision arises from our current lack of resources to implement this; however, we may contemplate opening direct applications in the future.
## **Funding priorities**
We aim to support underprivileged university students in the UK. We have decided to assist those pursuing degrees in medicine or engineering, as this was a particular wish of our late aunt.
## **Financial review**
As previously outlined, the endowment funds were temporarily held in reserve while the Trustees undertook a thorough process of due diligence to identify a suitable long-term investment. During the current financial year, following careful review of risk, performance, governance and ethical considerations, the Trustees invested £250,000 of the £310,000 endowment into a professionally managed medium-risk investment fund. This decision was taken to ensure that the endowment is safeguarded, appropriately diversified, and able to generate sustainable income in support of the charity’s long-term objectives. A summary of the endowment position and investment is included at the end of this report.
6
## **FUTURE PLANS**
In the coming financial year, the Trustees will continue to monitor the performance and risk profile of the endowment investment to ensure it remains appropriate and aligned with the charity’s long-term objectives.
The Trustees also intend to consider expanding the charity’s grant-making activities to include support for eligible beneficiaries outside the UK, with a particular focus on South Asia and Africa. Any such grants will be subject to appropriate due diligence, regulatory compliance, and assurance that funds are applied for charitable purposes and public benefit.
Signed on behalf of the Board of Trustees
Faisal Awan Trustee (Chair)
7
**The Mrs sardar Saied Charitable Trust 1196208**
## **Receipts and payments accounts**
**Receipts and payments accounts CC16a For the period** 01 April 2024 31 March 2025 **To from**
## **Section A Receipts and payments**
**Unrestricted Endowment Restricted funds Total funds Last year funds funds to the nearest £ to the nearest £ to the nearest £ to the nearest £ to the nearest £**
## **A1 Receipts**
|**A1 Receipts**|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**||
|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**||
|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**||
|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**||
|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**||
|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**||
|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**||
|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**||
|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**|||**-**|**--**||
|**_Sub total(Gross income for AR)_**|||||||||||||||||||||
**----- Start of picture text -----**
A2 Asset and investment sales, (see
table).
- - - -
- - - - -
Sub total - - - - -
Total receipts - - - - -
A3 Payments
- - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
Sub total - - - - -
**----- End of picture text -----**
**----- Start of picture text -----**
Sub total - - - - -
A4 Asset and investment
purchases, (see table)
Investment - - 250,000 250,000
**----- End of picture text -----**
CCXX R1 accounts (SS)
30/01/2026
1
||**-**
**--**||**-**
**--**||**-**
**--**|**-**
**--**|||
|---|---|---|---|---|---|---|---|---|
|**_Sub total_ -**
**--**
**_Total payments_ -**
**--**
**_Net of receipts/(payments)_ -**
**--**
**A5 Transfers between funds**
**-**
**--**
**A6 Cash funds last year end**
**-**
**--**
**_Cash funds this year end_ -**
**--**|**-**
**--**||**-**
**--**||**-**
**250,000-**|**-**
**250,000-**|||
||||||||||
||**-**
**--**||**-**
**--**||**-**
**250,000-**|**-**
**250,000-**||**-**
**--**|
||||||||||
||**-**
**--**||**-**
**--**||**-**
**250,000-**|**-**
**250,000-**||**-**
**--**|
||**-**
**--**||**-**
**--**||**-**
**--**
**-**
**310,000-**
**-**
**60,000-**|**-**
**--**
**-**
**310,000-**||**-**
**--**|
||**-**
**--**||**-**
**--**|||||**-**
**--**|
||**-**
**--**||**-**
**--**|||**-**
**60,000-**||**-**
**--**|
||||||||||
CCXX R2 accounts (SS)
30/01/2026
2
## **Section B Statement of assets and liabilities at the end of the period**
|**Categories**
**B1 Cash funds**|**Details**|**Details**|**Unrestricted**
**funds**
**to nearest £**|**Unrestricted**
**funds**
**to nearest £**|**Restricted funds**
**to nearest £**|**Restricted funds**
**to nearest £**|**Endowment**
**funds**
**to nearest £**|
|---|---|---|---|---|---|---|---|
||||**-**
**--**||**-**
**--**||**-**
**--**|
||Cash at bank (endowment)||**-**
**--**||**-**
**--**||**-**
**60,000-**|
||||**-**
**--**||**-**
**--**||**-**
**--**|
|**B2 Other monetary assets**
**B3 Investment assets**
**B4 Assets retained for the**
**charity’s own use**|**_Total cash funds_**
(agree balances with receipts and payments account
(s))
**Details**
**Details**
Medium risk investment fund (endowment)
**Details**||**-**
**--**||**-**
**--**||**-**
**60,000-**|
||||||||OK|
||||**Unrestricted**
**funds**
**to nearest £**
**-**
**--**
**-**
**--**
**-**
**--**
**-**
**--**
**-**
**--**
**-**
**--**
**Fund to which asset**
**belongs**
0
**Fund to which asset**
**belongs**||**Restricted funds**
**to nearest £**
**-**
**--**
**-**
**--**
**-**
**--**
**-**
**--**
**-**
**--**
**-**
**--**
**Cost (optional)**
**-**
**--**
**-**
**--**
**-**
**--**
**-**
**--**
**-**
**--**
**Cost (optional)**
**-**
**--**
**-**
**--**
**-**
**--**
**-**
**--**
**-**
**--**
**-**
**--**
**-**
**--**||**Endowment**
**funds**
**to nearest £**|
||||||||**-**
**--**|
||||||||**-**
**--**|
||||||||**-**
**--**|
||||||||**-**
**--**|
||||||||**-**
**--**|
||||||||**-**
**--**|
||||||||**Current value**
**(optional)**|
||||||||**-**
**--**|
||||||||**-**
**250,000-**|
||||||||**-**
**--**|
||||||||**-**
**--**|
||||||||**-**
**--**|
||||||||**Current value**
**(optional)**|
||||||**-**
**--**||**-**
**--**|
||||||**-**
**--**||**-**
**--**|
||||||**-**
**--**||**-**
**--**|
||||||**-**
**--**||**-**
**--**|
||||||**-**
**--**||**-**
**--**|
||||||**-**
**--**||**-**
**--**|
||||||**-**
**--**||**-**
**--**|
CCXX R3 accounts (SS)
30/01/2026
3
|||||||**-**|**--**||**-**|**--**|
|---|---|---|---|---|---|---|---|---|---|---|
|||||||**-**|**--**||**-**|**--**|
|||||**Fund to which**||**Amount due**||||**When due**|
||**Details**|||**liability relates**||**(optional)**||||**(optional)**|
|**B5 Liabilities**||||||**-**|**--**||||
|||||||**-**|**--**||||
|||||||**-**|**--**||||
|||||||**-**|**--**||||
|||||||**-**|**--**||||
|Signed by one or two trustees on behalf of
all the trustees||Signature||Print|Name||||Date of approval||
|||||Dr Faisal Awan||||||30/01/2026|
||||||||||||
CCXX R4 accounts (SS)
30/01/2026
4